Phages are viruses that attack bacteria by injecting their DNA, then usurping bacterial machinery to reproduce. Eventually, ...

Meet the jumbo phage. Scientists believe they’ve cracked the code on how its ‘secret handshakes’ act as a shield against the ...

In the spring, five patients with sickle cell disease began treatment with Casgevy, the first FDA-approved CRISPR-Cas9 gene editing treatment. The therapy—which involves removing blood stem ...

"We continue to work with urgency to bring forward the first CRISPR therapy for a genetic disease," said Nia Tatsis, Vertex' chief regulatory and quality officer, in a statement. The big question ...

The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...

Moreover, the company is pursuing in-house oncology and dementia therapeutic development, with a provisional patent already in place for a phage ... cells, CRISPR, and B-cell immuno-therapy ...

Some with severe sickle cell disease in England will now be able to access landmark CRISPR gene editing therapy, according to new health guidelines which were hailed as marking a “significant ...

Growth Drivers of The Gene Therapy Industry As per IMARC, the US gene therapy market size has been pegged at US$1,312.2 million in 2024. The market should reach US$3,697.8 million by 2033.

“which meant that the air was saturated with infectious wild type phage. I just could not maintain a PACE culture without it getting contaminated.” Even as other researchers swarmed into the nascent ...

to access its gene-edited therapy Casgevy, developed with CRISPR Therapeutics (NASDAQ:CRSP). The deal comes after the National Institute for Health and Care Excellence (NICE), which sets the drug ...